Clinical Trials Directory

Trials / Conditions / Ovarian

Ovarian

8 registered clinical trials studyying Ovarian — 2 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingProteomic Analysis of Patients Undergoing Bariatric Surgery
NCT06787807
Universidade Federal de PernambucoN/A
RecruitingStudy of IBI354 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Ovarian, Prim
NCT06834672
Innovent Biologics (Suzhou) Co. Ltd.Phase 3
Active Not RecruitingA Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.
NCT02734004
AstraZenecaPhase 1 / Phase 2
TerminatedStudy of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)
NCT02331251
Western Regional Medical CenterPhase 1 / Phase 2
CompletedOpen Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats
NCT01078662
AstraZenecaPhase 2
TerminatedEfficacy of Topotecan and Lapatinib in Early Recurrent Ovarian or Peritoneal Cancer
NCT00888810
Centre Francois BaclessePhase 2
CompletedPaclitaxel and CBT-1(Registered Trademark) to Treat Solid Tumors
NCT00972205
National Cancer Institute (NCI)N/A
CompletedSafety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced C
NCT00423254
Mannkind CorporationPhase 1